Retrospective Register for Uveal Melanoma
ConditionUveal Melanoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorMedical University of Vienna
About this trial
Background: Uveal melanoma (UM) is a common primary ocular malignancy associated with limited overall survival in the advanced stage of the disease. Fundamental breakthrough regarding the management of the disease and the overall-survival have not yet been achieved. Studies with large cohorts are difficult to perform due to limited patient numbers, therefore retrospective analyses are of great potential to gain further knowledge in a disease with high clinical needs.
Aim: The proposed project is a register for patients with UM treated at the Department of Ophthalmology and Optometry at the Medical University of Vienna between 01.01.1997 and 31.12.2021.
Patients and Methods: Patients treated for UM at the Department of Ophthalmology and Optometry at the Medical University of Vienna between 01.01.1997 and 31.12.2021 will be included in the register. Information on the baseline characteristics, survival times and course of the disease will be gathered via retrospective chart review and saved in a password-secured database.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients 18 - 99 years
Diagnosis of uveal melanoma
Disqualifiers
Patients younger than 18 years of age
Inadequate or missing information on the clinical course in patient charts
Trial population
Patients with uveal melanoma
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
any therapy suitable
Other interventionany therapy suitable
Treatment groups
1,400 Participants
are divided into 1 treatment groupGroup A: Uveal Melanoma1 intervention
Trial outcomes
Primary outcomes
1
Conduction of a Register providing the basis for
Retrospective studies analyzing the obtained data and easy identification of patients for prospective studies (e.g. long-term survival analysis)
Time frame
1997-2021Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov